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ABSTRACT
In animals, microRNAs (miRNAs) generally repress
gene expression by binding to sites in the
30-untranslated region (UTR) of target mRNAs.
miRNAs have also been reported to repress or
activate gene expression by binding to 50-UTR
sites, but the extent of such regulation and the
factors that govern these different responses are
unknown. Liver-specific miR-122 binds to sites
in the 50-UTR of hepatitis C virus (HCV) RNA and
positively regulates the viral life cycle, in part by
stimulating HCV translation. Here, we characterize
the features that allow miR-122 to activate
translation via the HCV 50-UTR. We find that this
regulation is a highly specialized process that
requires uncapped RNA, the HCV internal
ribosome entry site (IRES) and the 30 region of
miR-122. Translation activation does not involve a
previously proposed structural transition in the
HCV IRES and is mediated by Argonaute proteins.
This study provides an important insight into the
requirements for the miR-122–HCV interaction, and
the broader consequences of miRNAs binding to
50-UTR sites.
INTRODUCTION
MicroRNAs (miRNAs) are 21–23nt non-coding RNA
molecules that are expressed by a broad range of eukary-
otic species and are important regulators of many cellular
processes (1,2). Animal miRNAs generally repress gene
expression by binding to imperfectly complementary
sites in the 30-untranslated regions (UTRs) of target
mRNAs. The mechanism of repression is not fully under-
stood, although both translation inhibition and mRNA
degradation are implicated (1,2). miRNAs function in
association with a complex of proteins, including
an Argonaute (Ago) protein (3), known as the
miRNA-induced silencing complex (miRISC). Immuno-
precipitation of RNA regions bound by Ago and bio-
informatic analysis indicate that miRNA target sites
may also be located in the open reading frame (ORF)
and to a lesser extent in the 50-UTR (4–6). Although
miRNA repression via sites in actively translated ORFs
may be inhibited by translating ribosomes that displace
the miRISC (7), there are several mammalian examples
of miRNAs that mediate repression by binding to sites
in the ORF of target mRNAs (8–11).
A few experimental studies have shown miRNAs to
regulate gene expression by binding to 50-UTRs. Both
positive and negative effects were observed and it is not
clear what drives these different responses. Repression of
protein synthesis is directed by let-7 binding to multiple
sites located upstream of the hepatitis C virus (HCV)
internal ribosome entry site (IRES) in the 50-UTR of a
reporter mRNA (12). Repression via six 50-UTR sites in
a cap-dependent reporter mRNA is mediated by
Drosophila miR-2 (13). Such repression can also occur in
cellular mRNAs, as a human cytomegalovirus miRNA
down-regulates expression of a number of cellular
proteins by binding to sites in the 50-UTR of mRNAs
(14). Positive regulation via 50-UTR sites was observed
for miR-10a, which interacts directly with the 50 TOP
motif of ribosomal protein mRNAs and is involved in
the serum-dependent translational activation of these
messages (15), while miR-346 binds to a single site in the
receptor-interacting protein 140 (RIP140) 50-UTR and ac-
tivates translation independently of Ago proteins (16).
A detailed analysis of the mechanisms mediated by
miRNAs binding to 50-UTR sites is necessary to resolve
the different outcomes observed in these studies.
An important example of a miRNA that targets a
50-UTR is the liver-speciﬁc miR-122, which binds to two
adjacent sites upstream of the IRES in HCV genomic
RNA (Figure 1A) and is essential for HCV replication
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with a 9.6kb genome that establishes persistent infections
in the liver, eventually leading to cirrhosis and hepato-
cellular carcinoma (18). Following entry into cells, HCV
RNA ﬁrst serves as a template for translation of viral
proteins, which then mediate replication of the viral
RNA via a negative strand intermediate. Sequestration
of miR-122 by a locked nucleic acid (LNA)/DNA anti-
sense oligonucleotide reduced HCV titre in chronically
infected chimpanzees (19). The mechanism of regulation
is not fully understood; miR-122 stimulates translation via
the HCV 50-UTR (20), but this is not sufﬁcient to ex-
plain in full the effects of miR-122 on HCV replica-
tion, implying that a second regulatory process also
occurs (21).
In this study, we have analyzed the requirements for
miR-122 to stimulate translation via the HCV 50-UTR in
order to understand this important host–virus interaction
and to gain insight into the broader consequences of
miRNAs binding to 50-UTR sites. We used a luciferase
reporter RNA ﬂanked by the HCV 50- and 30-UTRs
to dissect individual components of this regulation
(Figure 1B), as miR-122 effectively stimulates translation
of such an RNA (20). This allowed us to determine the
requirements for a functional miR-122-HCV interaction
without complication from RNA sequence elements
involved in other aspects of the HCV life cycle. We
observe speciﬁc requirements for uncapped RNA, the
HCV IRES and the 30 region of miR-122 for this regula-
tion to occur. These features suggest that miRNA-
mediated translational stimulation via 50-UTR sites is a
highly specialized mechanism that is unlikely to be
widely used in cellular mRNAs, but could be applicable
to other viral systems. Finally, it has been shown in vitro
that miR-122 binding mediates a structural transition in
the viral IRES that was proposed to govern translational
stimulation by the miRNA (22). We see no evidence
for this mechanism in cultured cells. Our data suggest
instead that this activation is promoted directly by an
Ago-containing miRISC.
MATERIALS AND METHODS
Plasmid constructs
To generate p50LUC30, the T7 promoter and the HCV
50-UTR, including 11 amino acids of coding sequence,
were ampliﬁed from the plasmid pH77E1/p7 (a gift
A
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Figure 1. miR-122-dependent activation of HCV 50-UTR reporter RNA translation is substantially reduced by a cap and poly (A) tail. (A)
Schematic of HCV RNA with the structure of the IRES and the sequence of nucleotides 1–45, containing the two miR-122 seed matches, shown
in detail (genotype 1a). A model for two molecules of miR-122 binding via the seed and nucleotides 14–16, as proposed by Machlin et al. (33), is
shown. (B) The structure of the p50LUC30 plasmid and the 50LUC30 reporter RNA synthesized from this plasmid using the T7 promoter. The
locations of the two miR-122 seed matches are marked with asterisks. (C)5 0LUC30 RNA with or without an ARCA cap or a poly (A) tail was
introduced into Huh7 cells by transfection with a capped, polyadenylated Renilla luciferase RNA transfection control, in combination with a
randomized control 20-O-methylated oligonucleotide (Rand-20Ome), an antisense 20-O-methylated oligonucleotide to sequester miR-122
(122-20Ome), a wild-type miR-122 duplex (miR122wt), or a miR-122 duplex with mutations at p3+4 of the seed (miR122p3+4). Repression by
122-20Ome or activation by miR122wt was unaffected by a poly (A) tail alone, but signiﬁcantly inhibited by an ARCA cap (***P<0.0001 compared
to uncapped 50LUC30 RNA). The ARCA cap and poly (A) tail in combination abolished activation of translation by miR122wt, although repression
by 122-20Ome was still signiﬁcant (P<0.0001 compared to Rand-20Ome). Data are shown as ﬁreﬂy/Renilla luciferase activity at 6h post-transfection
and expressed as a percentage of the Rand-20Ome control for each RNA. All values are averages of three independent triplicate experiments, with
error bars representing standard deviation.
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50-UTR R and the HCV 30-UTR was ampliﬁed using
30-UTR F and 30-UTR R. These PCR products were
inserted ﬂanking the coding region of the ﬁreﬂy luciferase
expression vector pGL3-MCS (24) on HindIII-NcoI and
SpeI-EcoRI respectively. The HCV 50-UTR was replaced
with a longer variant including coding sequence to nu-
cleotide 538, ampliﬁed with 50-UTR F and 50core R, to
generate p50coreLUC30. Similarly, 1–45R was used as a
reverse primer to amplify only nucleotides 1–45 of the
HCV 50-UTR and create p1–45LUC30. The CSFV IRES
(Alfort Tu ¨ bingen strain) from domain II to amino acid
19 of coding sequence and the minimal FMDV IRES
(01k strain) were ampliﬁed from dicistronic plasmids
(gifts from Richard Jackson) using the primers
CSFV F and CSFV R, or FMDV F and FMDV R,
respectively. These IRESs were inserted at the NcoI site
in p1–45LUC30 to create p1–45CSFVLUC30 and p1–
45FMDVLUC30.
Mutagenesis of the miR-122 binding region was carried
out by overlap PCR and ligation of the mutant region in
place of the wild-type sequence between the KpnI and
NarI sites in p50LUC30. The outer primers used for the
generation of all mutants were Kpn F and LUC R and the
internal primers have the appropriate name for the
mutation incorporated. Mutagenesis of pH77E1/p7
was carried out by the same method, except that the
external primers were H77Xmn F and H77Kpn R and
the mutant PCR product was ligated into pH77E1/p7
between the XmnI and KpnI sites. To generate pHCV/
CSFVLUC30,p 5 0LUC30 was mutated to incorporate a
BssHII site at the 30-end of domain II of the HCV
IRES. CSFV IRES domain III was then ampliﬁed from
p1–45CSFVLUC30 using CSFVIII F and LUC R and
inserted between the BssHII and NarI sites in place of
the equivalent HCV sequence. p50coreLUC30 was used
as a template to create p50mutLRALUC30.
To generate the luciferase sensor plasmids pLUC21si,
pLUC122si, pLUC21/122si and pLUC21/26asi, the
forward primer LUC F and mutant reverse primers con-
taining an exactly complementary target for each miRNA
were used with pGL3-MCS as a template. The mutant
sequences were inserted in pGL3-MCS between the NarI
and EcoRI sites, such that the complementary miRNA
target sites were in the 30-UTR.
All primers were purchased from Invitrogen and the se-
quences are shown in Supplementary Table S1. pSV40-RL
(Promega) was used as a transfection control.
In vitro transcription
The plasmid p50LUC30 and its derivatives were linearized
with EcoRI and all other plasmids with XbaI. RNA was
synthesized using the T7 Megascript kit (Applied
Biosystems). To generate transcripts with poly (A) tails,
the poly (A) tailing kit (Applied Biosystems) was then
used. To synthesize m
7G- or A-capped transcripts,
anti-reverse cap analogue (ARCA) (Applied Biosystems)
or A(50)ppp(50)G (NEB) was included in the reaction mix
at 3.75mM and the GTP concentration was reduced to
3.75mM. 50-monophosphorylated RNA was generated by
treating 50-triphosphophorylated RNA with calf intestinal
alkaline phosphatase (NEB). RNA integrity was con-
ﬁrmed by denaturing agarose gel electrophoresis.
RNA and 20-O-methylated oligonucleotides
Synthetic miRNAs were introduced into cells as duplexes
based on the structure of the Dicer cleavage product of
the pre-miRNA. These were generated by annealing
the miRNA to the appropriate miRNA* sequence.
Where miRNA mutations resulted in disruption of the
duplex structure, appropriate mutant miRNA* molecules
were synthesized to restore base-pairing. The sequences of
20-O-methylated and RNA oligonucleotides (synthesized
by Dharmacon) are shown in Supplementary Tables S2
and S3.
Cell culture and transfection
Huh7 cells were maintained in DMEM supplemented with
10% fetal bovine serum, 1% non-essential amino acids
and L-glutamine (Invitrogen). Lipofectamine 2000
(Invitrogen) was used to transfect cells in 24-well plates.
Plating volumes of 1ml containing 0.2mg ﬁreﬂy luciferase
reporter RNA or plasmid DNA, 0.01mg capped,
polyadenylated Renilla luciferase control RNA or
pSV40-RL DNA and 20nM 20-O-methylated oligonucleo-
tide or miRNA duplex were assembled and 300ml applied
to each of three wells. Samples were harvested after 6h
(RNA transfections), 24h (luciferase sensor DNA trans-
fections) or 48h (p50LUC30 DNA transfections).
Luciferase activity was determined using the Dual
Luciferase Assay system (Promega) in a Glomax 96
microplate luminometer (Promega).
For electroporation, 5 10
6 Huh7 cells were
trypsinized, washed once in phosphate-buffered saline
and once in electroporation medium and resuspended in
1ml electroporation medium [75% cytomix (120mM KCl,
0.15mM CaCl2,1 0m MK 2HPO4, 25mM HEPES, 2mM
EDTA, 5mM MgCl2, pH 7.6), 25% phosphate-buffered
sucrose (277mM sucrose, 7mM KH2PO4, 1mM MgCl2,
pH 7.4)], containing 2mg luciferase RNA, 0.1mg capped,
polyadenylated Renilla luciferase control RNA and
200nM 20-O-methylated oligonucleotide or 5mg
H77E1/p7 RNA. Cells were pulsed twice in a 0.4cm
gap width cuvette at 900V, 25mF, and 1 resistance and
incubated at room temperature for 10min before plating.
Cells electroporated with luciferase RNA were harvested
at 6h. Cells containing H77E1/p7 RNA were transfected
with miRNA duplexes using lipofectamine 2000 at Days
 2 and +1 and harvested immediately after electropor-
ation at Day 0, and at Day+4, for m21A+B experiments.
Oligonucleotide and duplex transfections were carried out
at Day+3 and the cells harvested at Day+5 for mutLRA
experiments.
RNA isolation and northern blotting
RNA was harvested using TRI Reagent (Sigma).
Northern blotting was carried out as described (24),
using random-primed
32P-labeled DNA probes corres-
ponding to nucleotides 84–374 of the HCV IRES, the
7718 Nucleic Acids Research, 2011,Vol.39, No. 17entire coding region of ﬁreﬂy luciferase, or nucleotides
685–1171 of g-actin.
RNA interference
siRNAs were introduced into Huh7 cells in 6cm plates at
20nM total siRNA concentration using lipofectamine
RNAiMax (Invitrogen). Following a second siRNA hit
at 48h, cells were split into 24-well plates for transfection
and 6-well plates to harvest RNA. Transfections with
50LUC30 RNA were carried out at 72h post RNAi.
siRNAs with published sequences were used to target
the Ago mRNAs (25) and TNRC6B (26), and were
synthesized by Dharmacon. SMARTpool siRNAs were
used to target TNRC6A and Dicer and the control
siRNA was ON-TARGETplus Non-targeting siRNA #3
(Dharmacon).
Quantitative RT–PCR
Total RNA extracted from cells following RNAi was sub-
jected to reverse transcription with Superscript III
(Invitrogen). The resulting cDNA was analyzed by quan-
titative PCR using GoTaq (Promega) in a Stratagene
Mx3005P machine (Agilent Technologies). Primer
sequences are shown in Supplementary Table S1.
Statistical analysis
All statistical analysis was carried out using two-tailed
Student’s t-test for unpaired samples of equal variance.
P-values of <0.01, <0.001 and <0.0001 were considered
to represent degrees of signiﬁcance.
RESULTS
miR-122-dependent stimulation of HCV IRES-driven
translation is impeded by an m
7G cap
To test the requirements for miR-122 to activate trans-
lation via the HCV 50-UTR, we constructed a reporter
plasmid, p50LUC30, in which the ﬁreﬂy luciferase
coding region is ﬂanked by the complete HCV 50-
and 30-UTRs (genotype 1a) (Figure 1B). This plasmid
was linearized downstream of the HCV 30-UTR and
in vitro transcription carried out using the T7
promoter upstream of the HCV 50-UTR. The resulting
50LUC30 RNA has the exact 50-end of HCV (Figure
1B). HCV RNA does not have a 50 cap (27), so
in vitro transcribed uncapped 50LUC30 RNA mimics
the viral 50-UTR.
This reporter RNA was introduced into Huh7 human
liver cells by liposome-mediated transfection in combin-
ation with an antisense 20-O-methylated oligonucleotide
to sequester miR-122 (122-20Ome), a randomized control
20-O-methylated oligomer (Rand-20Ome), a synthetic
wild-type miR-122 duplex (miR122wt) or a control
miR-122 duplex with mutations at positions 3 and 4 to
abolish target interaction (miR122p3+4). These mol-
ecules have previously been used to effectively regulate
miR-122 activity (17,24). An in vitro transcribed Renilla
luciferase mRNA, with a cap and poly (A) tail introduced
in vitro to allow efﬁcient translation, was included in all
transfection experiments as a control, as Renilla luciferase
activity was unaffected by miR-122 (Supplementary
Figure S1A). Fireﬂy/Renilla luciferase activity was
determined as an average of three independent experi-
ments, each performed in triplicate and shown as a per-
centage of Rand-20Ome values for this and subsequent
experiments. miR-122 inhibition led to a decrease in
ﬁreﬂy luciferase expression and miR122wt overexpression
to an increase, similar to the observations of Henke et al.
(20) (Supplementary Figure S1B). miR-122 stimulates
luciferase expression at the level of translation, as RNA
levels and integrity were unaffected, as determined by
either transfection and subsequent electrophoresis of
radiolabeled 50LUC30 RNA, or qPCR with primers
directed against different regions of the reporter RNA
(Supplementary Figure S2). Quantiﬁcation of RNA fol-
lowing liposome-mediated translation may give inaccurate
results (28), so the 50LUC30 reporter RNA was also
introduced into Huh7 cells by electroporation. miR-122
sequestration inhibited luciferase expression in
electroporated cells without affecting the RNA level, con-
ﬁrming that miR-122 activates translation (Supplementary
Figure S3). The intracellular RNA level was not important
for miR-122 regulation, as electroporated and lipofected
RNA showed the same regulation despite different trans-
fection efﬁciencies. Subsequent experiments were carried
out using liposomal transfection.
When p50LUC30 DNA was introduced into Huh7
cells by transfection, luciferase expression was unaffect-
ed by miR-122 (Supplementary Figure S4) (20). This
suggested that features of the mRNA produced in
transfected cells, such as the 50 7-methylguanosine (m
7G)
cap and the poly (A) tail, might impede miR-122-
dependent translation stimulation. This hypothesis was
investigated by synthesis of 50LUC30 reporter RNA
bearing a 50 m
7G cap, incorporated using ARCA to
ensure the correct orientation of the cap structure, and/
or a poly (A) tail. These RNAs were introduced into Huh7
cells with or without sequestration or overexpression of
miR-122. We observed a signiﬁcant reduction in the
response to miR-122 in ARCA-capped RNA compared
to uncapped RNA, whereas a poly (A) tail alone did not
affect regulation by miR-122 (Figure 1C). The combin-
ation of an ARCA cap and a poly (A) tail reduced the
response to miR-122 more than an ARCA cap alone, such
that the RNA was completely resistant to translational
stimulation by miR122wt and only showed 9% inhibition
on transfection of 122-20Ome (Figure 1C). The inhibitory
effect of a 50 m
7G cap on miR-122 regulation is not due to
a speciﬁc requirement for the 50-triphosphate generated by
T7 RNA polymerase, as 50LUC30 RNA bearing an
inactive 50 ApppG cap or a 50-monophosphate showed
similar miR-122-dependent translation activation to
50-triphosphorylated 50LUC30 RNA (Supplementary
Figure S5). This implies that inhibition of miR-122 regu-
lation is due to speciﬁc functions of the m
7G cap, such as
recruitment of the eIF4F complex, and suggests it is
enhanced by the RNA circularization that occurs when
an mRNA is both capped and polyadenylated.
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activation of translation by miR-122
Stimulation of translation by miR-122 only requires the
50-UTR of HCV RNA, as it was unaffected when the
HCV 30-UTR in our reporter RNA was replaced by a
poly (A) tail (data not shown), so we analyzed the role
of 50-UTR elements in miR-122 regulation. HCV transla-
tion is driven by an IRES, a structured region of the
50-UTR that mediates cap-independent translation initi-
ation by directly recruiting 40S ribosomal subunits and
eIF3 and does not require most of the canonical eukary-
otic translation initiation factors (29). We tested the pos-
sibility that the mode of translation initiation inﬂuences
miR-122 regulation by replacing the HCV IRES in the
p50LUC30 plasmid with related or unrelated viral IRES
sequences. The classic swine fever virus (CSFV) or foot
and mouth disease virus (FMDV) IRES was inserted
downstream of nucleotides 1–45 of the HCV 50-UTR,
which contain the miR-122 binding sites (Figure 2A).
The FMDV IRES has a distinct sequence, structure and
mechanism to the HCV IRES, requiring all the canonical
translation initiation factors except eIF4E and some add-
itional trans-acting factors (30). By contrast, the second-
ary structure and mechanism of the CSFV IRES are very
similar to those of the HCV IRES (29). Reporter RNA
synthesized from these plasmids was introduced into
Huh7 cells with sequestration or overexpression of
miR-122 (Figure 2C). RNA molecules containing either
the CSFV or FMDV IRES showed a considerable reduc-
tion in the response to miR-122 compared to the wild-type
HCV IRES-driven 50LUC30 RNA. The responses of the
CSFV and FMDV IRESs did not differ signiﬁcantly. This
indicates that there is a speciﬁc role for the HCV IRES in
effective miR-122-mediated translation activation that is
not due to its mechanism of translation initiation.
We took advantage of the similar structures of the HCV
and CSFV IRESs to construct a reporter RNA with a
chimeric IRES, in which domains I (including the
miR-122 binding sites) and II of the HCV 50-UTR are
fused to domain III of the CSFV IRES (Figure 2B).
This RNA showed a reduction in miR-122-dependent
translation stimulation compared to 50LUC30 RNA,
similar to that observed with the full CSFV IRES
(Figure 2C). Full translation stimulation by miR-122
therefore shows a speciﬁc requirement for HCV IRES
sequence or structural features downstream of domain II.
The 30 region of miR-122 is necessary for activation
of translation
As miRNAs binding to 50-UTRs mediate different re-
sponses in different studies, we considered the possibility
that the identity of the miRNA might inﬂuence the mech-
anism used. The major determinant of a functional
miRNA interaction is exact Watson–Crick base-pairing
of nucleotides 2–7 or 2–8 of the miRNA, known as the
seed, to the target site (31). To test whether a different
miRNA can replace miR-122 in translational stimulation,
we mutated both miR-122 seed matches in the p50LUC30
reporter plasmid to miR-21 seed matches (Figure 3A).
In vitro transcribed 50m21A+BLUC30 mutant RNA was
introduced into Huh7 cells, which express miR-21, with
20-O-methylated complementary oligonucleotides to
sequester either miR-122 or miR-21 (Figure 3B). Sensor
plasmids with exactly complementary sites for miR-21 or
miR-122 in the luciferase 30-UTR conﬁrmed that both
inhibitors were effective (Supplementary Figure S6B).
Luciferase activity from 50m21A+BLUC30 RNA was
not affected by sequestration of miR-21 (Figure 3B),
indicating that endogenous miR-21 cannot activate trans-
lation via miR-21 seed matches in the HCV 50-UTR.
A
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Figure 2. The HCV IRES is necessary for full regulation of translation by miR-122. (A) The HCV IRES was excised from the plasmid encoding
50LUC30 RNA and replaced by either the CSFV or FMDV IRES downstream of HCV nucleotides 1–45, which contain the miR-122 binding sites.
(B) The HCV IRES downstream of HCV nucleotides 1–45 was replaced by a chimeric IRES in which HCV IRES domain II was fused to CSFV
IRES domain III. (C) RNA synthesized from these plasmids was introduced into Huh7 cells by transfection with sequestration or overexpression of
miR-122, with a capped, polyadenylated Renilla luciferase RNA transfection control. Average ﬁreﬂy/Renilla luciferase activity from three independ-
ent triplicate experiments is shown as a percentage of the Rand-20Ome values for each RNA. Error bars represent standard deviation. The CSFV,
FMDV and chimeric IRES RNAs all showed a signiﬁcantly reduced response to sequestration and overexpression of miR-122 compared to 50LUC30
RNA (***P<0.0001).
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miR-122 because miRNA features other than seed com-
plementarity are required, we synthesized a chimeric
miRNA in which the ﬁrst 8nt of miR-21 (the seed) are
fused to nucleotides 9–23 of miR-122 (Figure 3C). This
was annealed to a chimeric passenger strand to generate a
chimeric miR21/122 duplex, which was effectively
incorporated into miRISC following transfection as it
A
C
EF
B
D
Figure 3. The 30 region of miR-122 is necessary for stimulation of translation. (A)5 0m21A+BLUC30 RNA was generated from a p50LUC30 plasmid
in which both miR-122 seed matches were mutated to miR-21 seed matches. (B)5 0m21A+BLUC30 RNA and the Renilla luciferase control RNA
were introduced into Huh7 cells with 20-O-methylated antisense oligonucleotides to sequester either miR-122 or miR-21 (122-20Ome or 21-20Ome), or
a randomized control (Rand-20Ome), and showed no response to endogenous miR-21. Average ﬁreﬂy/Renilla luciferase activity across three inde-
pendent triplicate experiments is shown as a percentage of the Rand-20Ome values. Error bars represent standard deviation. (C) The sequences of
transfected miRNAs. (D) RNA molecules with miR-21 seed matches at site A, site B, or A+B were introduced into Huh7 cells with overexpression
of miR122p3+4, miR122wt, miR21wt or a miR21/122 chimera in which nucleotides 1–8 of miR-21 are fused to nucleotides 9–23 of miR-122.
(E) Both miR-122 seed matches were mutated to miR-21 seed matches in a plasmid encoding a replication-competent H77E1/p7 HCV RNA.
Wild-type and mutant RNAs were introduced into Huh7 cells by electroporation, with transfection of miR122wt or miR21/122. HCV RNA was
detected by northern blotting, with g-actin as a loading control. At 4 days post electroporation, m21A+B mutant HCV did not replicate to a
detectable level even when miR21/122 was present in the cells. (F) Similar to (D), except that individual nucleotides were mutated to test more
precisely the requirements for translation activation. For both (D) and (F), luciferase activity is shown as in (B) but as a percentage of miR122p3+4
values for each RNA (*P<0.01; **P<0.001; ***P<0.0001 compared to miR122p3+4). miR21/122 effectively stimulated translation via the
miR-21 seed matches and nucleotide 16 and 21–23 of miR-122 were important for this regulation.
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Figure S6C). This miR21/122 chimera strongly stimulated
translation of 50m21A+BLUC30 RNA (Figure 3D),
whereas overexpression of wild-type miR-21 only
resulted in a very small increase in translation that is
unlikely to be biologically relevant. This indicates that
elements within nucleotides 9–23 of miR-122 are
required for activation of translation, but that the only
important feature of the miRNA seed is its complemen-
tarity to the target site. Examination of reporter RNAs
with a single miR-21 seed match indicated that, whereas
miR-122 regulated translation to a similar extent via both
seed matches, activation of translation by miR21/122 was
more efﬁcient via miR-21 seed match A than seed match B
(Figure 3D).
We have previously shown that a full length HCV RNA
in which seed match A is mutated to a miR-21 seed match
does not replicate in cells containing endogenous miR-21
(24). This ﬁts with the requirement we now observe for the
30 region of miR-122. To test this further, we mutated both
miR-122 seed matches to miR-21 seed matches in a
plasmid encoding a replication-competent HCV RNA
that has the E1-p7 coding region deleted to prevent
formation of infectious virus (genotype 1a, strain H77)
(23). This mutant RNA was introduced into Huh7 cells
with overexpression of miR122wt or miR21/122, but did
not replicate to a detectable level even in the presence
of miR21/122 (Figure 3E). Replication of wild-type
H77E1/p7 RNA was stimulated by transfection with
wild-type miR-122, indicating that miRNA over-
expression was effective (Figure 3E). This suggests that,
in the context of replicating HCV, the sequence of the
miR-122 binding region is critical for other aspects of
the HCV life cycle in addition to miR-122 interaction.
The role of the 30 region of miR-122 in translation
activation was further probed by the cotransfection of
additional miRNA mutants with 50m21A+BLUC30,
50m21ALUC30 and 50m21BLUC30 RNA. To exclude the
possibility that the 30 region of miR-21 speciﬁcally
prevents translation activation, a second chimeric
miRNA, in which the seed of miR-21 is fused to the 30
region of miR-26a, was tested and only slightly enhanced
translation (miR21/26a, Figure 3F). Contiguous 4nt
pairing starting at nucleotides 12, 13 or 14 of a miRNA
is a feature of some miRNA target sites (32) and an inter-
action between GCCA at nucleotides 1–4 of the HCV
50-UTR and UGGU at nucleotides 14–17 of miR-122
binding to site A was recently shown to be essential for
miR-122 to regulate HCV replication (Figure 1A) (33).
The requirement for the 30 region of miR-122 to activate
translation might be due to a need for base-pairing
between these nucleotides. miR-21 mutated to give the
miR-122 UGGU sequence at nucleotides 14–17 in place
of the miR-21 UGAU sequence mediated a slight en-
hancement in translation of all three reporter RNAs
(miR21p16, Figure 3F). This suggests that interaction
with nucleotides 2–4 of HCV may make a contribution
to translation stimulation, but there is an additional role
for the 30 region of miR-122 in this regulation other than
interaction with these nucleotides. The slight stimulation
mediated by miR21/26a could be due to base-pairing
between the GG at nucleotide 14–15 of miR21/26a
(Figure 3C) and nucleotides 2 and 3 of HCV.
Individual nucleotides that differ between miR-21 and
miR-122 were mutated in the miR21/122 chimera to de-
termine the features of the 30 region of miR-122 that allow
translation stimulation. A chimera with nucleotides 9 and
11 of miR-122 mutated to the miR-21 sequence was as
effective as miR21/122 in stimulating translation
(miR21/122p9,11, Figure 3F). Nucleotide 16 of miR-122
was essential for activation of translation, which is likely
to be due to an interaction with nucleotide 2 of HCV
RNA as discussed above (miR21/122p16, Figure 3F).
Interestingly, we found that nucleotides 21–23 of
miR-122 also make a strong contribution to translation
stimulation (miR21/122p21-3, Figure 3F). This is an im-
portant observation, as these nucleotides are not predicted
to interact with the RNA target.
Target site sequence requirements for miR-122
to activate translation
The importance of nucleotide 16 of miR-122 for transla-
tion stimulation suggested that the interactions between
nucleotides 14–17 of miR-122 and the HCV 50-UTR that
are required for miR-122 to regulate HCV replication (33)
(Figure 1A) are also necessary for regulation of transla-
tion. This possibility was tested by mutagenesis of various
sequence elements in 50LUC30 RNA.
Mutation of nucleotides 2–4 in the 50LUC30 reporter
RNA (Figure 4A) resulted in a slight decrease in the
response to miR-122 in Huh7 cells, suggesting that
pairing to this sequence might also be important for
miR-122 to activate translation (Figure 4B). We could
not mutate the G at nucleotide 1 of 50LUC30 RNA as it
is required by the T7 promoter. The nucleotides 2–4
mutation was combined with a second mutation at pos-
itions 3 and 4 of seed match B in order to distinguish
between translation activation via seed matches A
(mediated by miR122wt) and B (mediated by
miR122p3+4) (Figure 4A). Translation of this mutant
reporter RNA was activated by miR122p3+4 but not
by endogenous or overexpressed wild-type miR-122
(Figure 4B), indicating that nucleotides 2–4 of the HCV
50-UTR are required for translational activation via seed
match A.
A miR-122 molecule binding to seed match B could
potentially pair with several nucleotides in the 8nt
spacer separating the two sites and also with nucleotides
within an unoccupied seed match A (Figure 4C). We have
shown previously that mutation or deletion of the two Cs
in the spacer strongly inhibits replication of full length
HCV RNA (24) and it was recently demonstrated that
this requirement is due to an interaction with the GG
motif at nucleotides 15 and 16 of miR-122 (33). Each nu-
cleotide in the spacer was mutated to its complement in
the 50LUC30 reporter RNA to disrupt any pairing to this
region (Figure 4C). Following transfection into Huh7
cells, this mutant reporter (50m30-7LUC30) responded to
miR-122 sequestration or overexpression to the same
extent as the wild-type 50LUC30 reporter RNA (Figure
4D). Additionally, effective translation stimulation by
7722 Nucleic Acids Research, 2011,Vol.39, No. 17miR21/122 binding to the 50m21A+BLUC30 reporter
suggests that interaction between a miRNA bound to
seed match B and sequence elements in seed match A is
unlikely to be necessary for function.
Taken together, these mutagenesis experiments demon-
strate that, although some base-pairing outside the
miR-122 seed matches is important for translation stimu-
lation, the 30 region of miR-122 has a speciﬁc role in this
regulation that is independent of target binding.
The role of target site location in miR-122-mediated
activation of translation
As the location and spacing of the miR-122 seed matches
in HCV is highly conserved (24), we tested whether the
location of these sites relative to the RNA 50-end and the
HCV IRES is important. 50LUC30 RNA was extended at
the 50-end by a 31nt sequence derived from the ﬁrst 45nt
of the HCV 50-UTR. Stem-loop I (SLI) is not required
for miR-122 to activate translation (Supplementary
Figure S7) so was not included in the extension. To dis-
tinguish between regulation via upstream and downstream
sites, we tested versions of this reporter with miR-122 seed
matches in either the extension or the original 50-UTR
replaced by miR-21 seed matches (Figure 5A). The
presence of a 50 extension slightly enhanced the response
to 122-20Ome via miR-122 sites in the original 50-UTR,
but this was the only difference in miR-122 regulation of
these reporters and 50LUC30 RNA (Figure 5B), suggesting
that site location is not critical for function. Interestingly,
miR21/122 did not stimulate translation as effectively via
seed matches in either of the extended RNA reporters as it
did in 50m21A+BLUC30 RNA (Figure 5C). The reason
for this is not clear, but the similar response of both
extended reporters supports the conclusion that the
location of the seed matches relative to either the 50-end
or the HCV IRES is not important, at least within the
nucleotide lengths we have tested.
The inﬂuence of site location relative to the HCV IRES
was further tested by insertion of an 8nt spacer between
seed match B and SLII of the IRES in 50LUC30 reporter
RNA to generate 50spacer2LUC30 RNA (Figure 5D). This
additional spacer sequence led to a slight increase in re-
pression by sequestration of endogenous miR-122, but
did not affect activation by overexpressed miR-122
(Figure 5E). Analysis of reporters with p3+4 mutant
seed match A or seed match B indicated that the spacer
did not consistently affect activation of translation via
either seed match (Supplementary Figure S8). This
supports our conclusion that a small increase in the
distance between the miR-122 seed matches and the
HCV IRES does not affect translation regulation.
A
B
C
D
Figure 4. The sequence of nucleotides 2–4 of HCV RNA is important for translational regulation by miR-122. (A) Model for a miR-122 molecule
binding to seed match A in HCV nucleotides 1–45 and making additional contacts with nucleotides 1–4. This was tested by mutating nucleotides 2–4
in 50LUC30 RNA with or without mutations at p3+4 of seed match B. (B) The mutant RNAs in (A) were introduced into Huh7 cells by
transfection, with sequestration or overexpression of miR-122. Mutation of nucleotides 2–4 abolished regulation by miR122 via seed match A in
the context of a p3+4 mutant seed match B (***P<0.0001). (C) Model for miR-122 binding to seed match B in HCV nucleotides 1–45 and making
additional contacts with the spacer and an unoccupied seed match A. The spacer was mutated as shown. (D)5 0m30-7LUC30 RNA was introduced
into Huh7 cells with sequestration or overexpression of miR-122 and did not show a signiﬁcant difference in the response to miR-122 compared to
wild-type 50LUC30 RNA. All values are ﬁreﬂy luciferase activity relative to Renilla luciferase activity from the transfection control, as a percentage of
Rand-20Ome values for each RNA. The average of three independent triplicate experiments is shown, with error bars representing standard
deviation.
Nucleic Acids Research, 2011,Vol.39, No. 17 7723miR-122 does not regulate HCV translation by disruption
of an inhibitory interaction between the miR-122 binding
sites and the HCV ORF
An in vitro structure probing study of HCV RNA sug-
gested that miR-122 acts by disruption of an inhibitory
long-range annealing (LRA) motif that forms between the
miR-122 binding region and part of the core protein
coding sequence (22). However, miR-122 stimulates trans-
lation in our 50LUC30 RNA, which does not include the
ORF sequence predicted to form the LRA, suggesting that
miR-122 may activate translation by an alternative mech-
anism. To test whether this interaction is involved in the
response to miR-122 in Huh7 cells, part of the core coding
sequence, including the region predicted to form the LRA,
was fused to the HCV IRES in the plasmid encoding
50LUC30 RNA (Figure 6A). The 50coreLUC30 RNA
synthesized from this plasmid responded to miR-122 in
the same manner as 50LUC30 RNA (Figure 6B). The mu-
tations that had previously been shown to enhance HCV
IRES activity in a dicistronic luciferase reporter plasmid
by disrupting the LRA, while maintaining the amino acid
sequence (34), were introduced into the core coding
sequence in 50coreLUC30 RNA (Figure 6A). These muta-
tions had no effect on the response to miR-122, so trans-
lational regulation in this RNA reporter is not affected by
this tertiary interaction (Figure 6B). We also introduced
the same mutations into the core coding sequence in the
plasmid encoding H77E1/p7 RNA. We observed no dif-
ference in HCV replication in Huh7 cells or in the
response to miR-122 between the wild-type and mutant
RNAs (Figure 6C). We conclude that this particular
LRA is not involved in activation of translation by
miR-122. Our observation that translational regulation
can still occur even when the binding site is extensively
mutated implies that miR-122 is unlikely to function by
disruption of alternative inhibitory interactions.
The Ago proteins are required for miR-122 to activate
translation via the HCV 50-UTR
miRNA repression via a 30-UTR requires an Ago protein,
of which there are four in mammals, to function as part of
the miRISC (3). The role for Ago proteins in regulation
AD
BC E
Figure 5. The location of the miR-122 binding sites relative to the HCV IRES and 50-end is not important for translation stimulation by miR-122.
(A)5 0LUC30 RNA was extended by 31 nucleotides at the 50-end. The extension comprised nucleotides 1–45 of 50LUC30 RNA with SLI deleted.
Variants were generated with either the miR-122 seed matches in the extension or in the original 50-UTR replaced by miR-21 seed matches, so that
regulation via upstream or downstream sites could be distinguished. (B) Both extended RNA reporters were introduced into Huh7 cells with
sequestration of miR-122 or overexpression of miR122wt or miR21/122. Regulation by miR-122 via upstream or downstream seed matches was
similar to that observed in 50LUC30 RNA. (C) Activation of translation by miR21/122 binding to miR-21 seed matches was signiﬁcantly reduced in
both extended RNAs compared to 50m21A+BLUC30 RNA. (D) A mutant 8nt spacer sequence was introduced downstream of seed match B in
50LUC30 reporter RNA. (E)5 0spacer2LUC30 RNA was introduced into Huh7 cells with sequestration or overexpression of wild-type miR-122.
Repression by 122-20Ome was slightly enhanced, but activation by miR122wt was unaffected. All data are shown as average ﬁreﬂy luciferase activity
relative to Renilla luciferase activity from the transfection control for three independent triplicate experiments, as a percentage of Rand-20Ome or
miR122p3+4 values. Error bars represent standard deviation. (***P<0.0001).
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translation via a 50-UTR site functions independently of
Ago (16). Depletion of Ago proteins by RNAi resulted in
inhibition of HCV replication (35) and Ago2 was shown
to be necessary for miR-122 to stimulate both translation
and replication of HCV (36). However, a recent study
showing that miR-122 overexpression overcame the inhib-
ition of HCV replication following Ago RNAi suggested
an Ago-independent mechanism might operate (33). To
test whether Ago proteins are necessary for miR-122
to activate translation in our system, we used RNAi
to deplete Ago1 or Ago2 individually, or all four Ago
proteins together, in Huh7 cells. The cells were then trans-
fected with 50LUC30 RNA, with sequestration or
overexpression of miR-122 (Figure 7A). RNAi was effect-
ive (Figure 7B and C) and depletion of Ago1, Ago2, or
Ago1–4 led to a considerable reduction in translation ac-
tivation by miR-122 compared to a control non-targeting
siRNA transfection. The data are expressed relative to the
Rand-20Ome control in cells transfected with control
siRNA and show that basal luciferase activity following
sequestration of miR-122 did not decrease following
RNAi to the Ago proteins (122-20Ome, Figure 7A). This
indicates that the Ago proteins are speciﬁcally required for
miR-122 to activate translation in 50LUC30 and do not
have other effects on HCV IRES-driven translation.
The Ago proteins are involved in miRNA biogenesis
and stability (37) and we observed a reduction in the
level of endogenous miR-122 following Ago1–4 RNAi
that might explain the reduction in regulation of
50LUC30 translation (data not shown). However,
miR122wt was overexpressed in these experiments as a
duplex, thus bypassing much of the miRNA biogenesis
pathway, and substantially raised the cellular levels of
miR-122 whether or not Ago1–4 RNAi was carried out
(data not shown). Ago1–4 RNAi inhibited translation
activation by overexpressed miR122wt (Figure 7A),
implying that the requirement for the Ago proteins in
this regulation is due to their function within the RISC
and not their role in miR-122 biogenesis. This was sup-
ported by our observation that RNAi to the miRNA bio-
genesis enzyme Dicer did not affect regulation of 50LUC30
translation by miR-122 (Figure 7D) despite effective
depletion (Figure 7F). We also tested the role of the
GW182 proteins (TNRC6A-C in mammals), as these are
essential for miRNA-mediated repression of gene expres-
sion (2). We used siRNAs targeting both TNRC6A and
TNRC6B, a combination that effectively derepresses
miRNA-targeted mRNAs (26). RNAi was effective
(Figure 7E) and reduced the translational activation by
miR122wt (Figure 7D). Depletion of these proteins did
not have as much effect on miR-122-mediated regulation
of 50LUC30 translation as Ago1–4 RNAi, so it is not clear
whether TNRC6 proteins are essential for this regulation.
DISCUSSION
This study has expanded our understanding of the features
governing the interaction between miR-122 and HCV
RNA and the effects of miRNAs binding to 50-UTR
sites. Translational regulation in this system is a highly
specialized process that is dependent on speciﬁc regions
of both the HCV IRES and miR-122. It also requires
uncapped RNA, which implies that miRNAs binding to
50-UTR sites in capped cellular mRNAs are unlikely to use
a similar mechanism of translational activation.
The inhibitory effect of a 50 m
7G cap that we observe is
likely to explain the lack of regulation observed in plasmid
A
B
C
Figure 6. miR-122 does not activate translation by disruption of a
proposed long-range annealing (LRA) motif. (A) Part of the HCV
core protein coding region, encompassing the sequence predicted to
form an LRA with the miR-122 binding site, was fused in frame
to the HCV IRES in p50LUC30 to generate a plasmid encoding
50coreLUC30 RNA. The 50mutLRALUC30 RNA has three point muta-
tions that disrupt the LRA while maintaining the amino acid sequence.
(B)5 0coreLUC30 and 50mutLRALUC30 RNA were introduced into
Huh7 cells with sequestration or overexpression of miR-122. Fireﬂy
luciferase activity is shown relative to Renilla luciferase activity of the
transfection control as a percentage of the Rand-20Ome values for each
RNA. Data are an average of three independent triplicate experiments
and error bars represent standard deviation. The responses of
50coreLUC30 and 50mutLRALUC30 to 122-20Ome or miR122wt did
not differ signiﬁcantly to that of 50LUC30 RNA. (C) The mutation to
the LRA shown in (A) was introduced into a plasmid encoding
replication-competent H77E1/p7 HCV RNA. Wild-type and mutant
RNA were introduced into Huh7 cells and HCV RNA levels after
5 days were determined by northern blotting following sequestration
or overexpression of miR-122. g-actin RNA is shown as a loading
control. The LRA mutation did not affect HCV RNA abundance or
the response to miR-122.
Nucleic Acids Research, 2011,Vol.39, No. 17 7725DNA transfections (Figure 1C). As the miR-122 binding
sites are very close to the 50-end of the RNA, it is possible
that the eIF4F protein factor complex recruited by the
cap impedes interaction of miR-122-RISC with the
RNA. It is also possible that the helicase eIF4A, which
is part of eIF4F, could release bound miR-122 from the
RNA. The stronger inhibition of the response to miR-122
in RNA bearing a poly (A) tail in addition to an ARCA
A
DE
B
F
C
Figure 7. Ago proteins are required for miR-122 to activate translation via the HCV 50UTR. (A) Huh7 cells were transfected with siRNAs directed
against Ago1, Ago2 or all four Ago mRNAs before transfection with 50LUC30 RNA and the Renilla luciferase control RNA and sequestration or
overexpression of miR-122. Depletion of the Ago proteins reduced translational activation by miR-122. Average ﬁreﬂy/Renilla luciferase activity of
three independent triplicate experiments is shown as a percentage of the Rand-20Ome control in control siRNA-treated cells. (B) qPCR was carried
out to detect Ago1 mRNA following RNAi to Ago1 or Ago1–4. Data are shown as 2
 Ct relative to a GAPDH mRNA control as a percentage of
the value obtained on control siRNA transfection and are an average of three independent experiments. (C) As (B), except that qPCR was used to
detect Ago2 mRNA following RNAi to Ago2 or Ago1–4. RNAi against both Ago1 and Ago2 was effective. (D) Similar to (A), except that siRNAs
directed against both TNRC6A and TNRC6B, or against Dicer, were used. RNAi to TNRC6A+B, but not Dicer, reduced activation by miR122wt.
(E) qPCR was used to detect TNRC6A and TNR6CB mRNA. Data are expressed as 2
 Ct relative to actin mRNA as an average of two
independent RNAi experiments and indicate that RNAi was effective. (F) qPCR was used to detect Dicer mRNA following RNAi and average
2
 Ct values of three independent experiments are shown relative to GAPDH mRNA. RNAi was effective. All error bars represent standard
deviation. (*P<0.01; **P<0.001; ***P<0.0001 compared to control siRNA).
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cap-binding complex when a poly (A) tail allows mRNA
circularization. Although the HCV IRES is highly
structured and would be expected to act as a barrier to
scanning ribosomes, it is possible that this capped,
polyadenylated mRNA might undergo cap-dependent
translation initiation during which the IRES is unwound
and would thus lose miR-122 regulation, for which the
HCV IRES is necessary (Figure 2C). Current evidence
indicates that HCV RNA is uncapped and has
a phosphorylated 50-end (27). The requirement for
uncapped RNA for miRNA-dependent translational
stimulation suggests that similar regulation would not
occur in the context of cellular mRNAs, but has potential
applicability to other uncapped viral RNAs. It is possible
that cellular mRNAs in which translation is driven by an
IRES might be subject to similar regulatory mechanisms if
the miRNA binding sites were sufﬁciently distant from the
cap to prevent interference by eIF4F.
Interestingly, we saw no repression of translation by
either miR-122 or miR-21 binding to the 50-UTR sites in
our reporters following DNA or capped mRNA transfec-
tion (Supplementary Figure 4, and data not shown).
This is in contrast to a study that showed repression
mediated by miRNAs binding to 50-UTR sites upstream
of the HCV IRES in a reporter plasmid (12). The plasmid
used by Lytle et al. (12) contained four miRNA binding
sites, whereas our reporter only has two sites, which might
explain this discrepancy. The number of sites in a 50-UTR
may be an important factor in allowing miRNA repres-
sion, as Drosophila miR-2 effectively represses translation
via six, but not one or two, 50-UTR sites in a reporter
plasmid (13). However, a human cytomegalovirus
(HCMV) miRNA predominantly targets 50-UTRs of
cellular mRNAs and mediates translational repression,
for which single sites appear to be sufﬁcient (14). This
suggests that speciﬁc features of the target site or the
miRNA may allow miRNAs to mediate repression via
50-UTR sites.
Our results strongly imply that translation activation
via the 50-UTR requires speciﬁc features of both the
miRNA and the target RNA. This regulation shows a re-
quirement for the 30 region of miR-122 that is independent
of target interaction (Figure 3F). The importance of
nucleotides 16 and 21–23 of miR-122 for translation regu-
lation via both seed matches parallel the roles for these
nucleotides in regulation of HCV replication observed by
Machlin et al. (33) (Figure 3F). It has generally been
thought that miRNAs function to recruit a common
miRISC to distinct target sequences, based primarily on
seed complementarity. However, recent evidence suggests
that sequence features within a miRNA may have import-
ant roles in addition to target interaction. Some miRNAs
are subject to 30 modiﬁcation, including miR-122, which
has a single adenosine added to the 30-end by GLD-2 that
increases its stability (38). It is possible that there may be
additional functional roles for this modiﬁcation that are
not achieved by miRNAs with different 30-ends. The
miR-122 30-end may have a role in the recruitment of
speciﬁc miRISC proteins or cofactors that mediate trans-
lation activation, or may form intra- or inter-molecular
RNA–RNA interactions that are important for function,
or affect subcellular localization. Further experimentation
will be important to establish the role of the miR-122
30-end in this regulation. The highly conserved sequence
of many miRNAs, including miR-122, which has an iden-
tical sequence in humans and zebraﬁsh, implies that
features of the miRNA other than the seed sequence are
important for function. It will be intriguing to see whether
other miRNA 30-ends allow specialized functions and
whether the miR-122 30-end is necessary for the regulation
of additional miR-122 targets.
We ﬁnd that the Ago proteins are required for miR-122
to activate translation via the HCV 50-UTR (Figure 7A).
This observation is supported by a recent study
demonstrating that Ago2 is necessary for miR-122 to
stimulate translation of HCV replicons (36), although
the role of Ago proteins in miR-122-mediated regulation
of HCV remains controversial (33). TNRC6 proteins also
contribute to translation activation by miR-122, but do
not have as great an effect on this process as Ago
proteins (Figure 7D). This partial effect might be due to
incomplete depletion of the proteins or to compensation
by TNRC6C, although RNAi to TNRC6A and TNRC6B
was sufﬁcient to inhibit miRNA-mediated repression (26).
The exact role of the TNRC6 proteins and the question of
whether Ago proteins function as part of a specialized
miRISC are currently under investigation.
The HCV IRES is a further major feature that is im-
portant for miR-122 to stimulate translation via a 50-UTR
(Figure 2C). The inability of the closely related CSFV
IRES to substitute effectively for the HCV IRES
suggests that IRES features other than the mechanism of
translation initiation determine effective regulation by
miR-122. The HCV and CSFV IRESs have numerous dif-
ferences in sequence and a few differences in secondary
structure (29), so it is possible that miR-122 regulates
the formation of an HCV IRES-speciﬁc structure or inter-
acts with HCV IRES-speciﬁc RNA sequence. miR-122
was shown to act by disrupting an inhibitory RNA struc-
tural motif in vitro (22), but we do not see any evidence for
this in cells (Figure 6B and C). It is unlikely that miR-122
functions by disrupting a direct interaction between its
binding sites and a different part of the HCV IRES, as
translational stimulation can be effectively maintained
when the miR-122 binding region is extensively mutated
(Figures 3 and 4). It remains possible that miR-122
binding may mediate a switch to a more active conform-
ation of the IRES in a manner that requires sequence or
structural elements of HCV IRES domain III/IV. A
second possibility is that one or more protein factors
that bind speciﬁcally to the HCV IRES are involved in
regulation by miR-122. We observe some miR-122-
mediated translation stimulation when translation is
driven by the CSFV or FMDV IRES. This suggests that
features within the HCV IRES allow enhancement of a
basal level of miRNA regulation, or that two distinct regu-
latory processes occur, only one of which requires the
HCV IRES.
In general, there are few sequence elements within nu-
cleotides 1–45 of HCV RNA that are necessary for
miR-122 to stimulate translation. Both seed matches can
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by miR21/122 (Figure 3D) and activation of translation is
not inhibited by mutagenesis of the spacer or deletion of
SLI. An important exception is a requirement for nucleo-
tides 2–4 of HCV RNA to allow translation stimulation
via seed match A (Figure 4B), which is likely to be due to
base-pairing to nucleotides 14–16 of miR-122. The
location of the miR-122 binding sites relative to the
50-end of the RNA and the HCV IRES does not appear
to inﬂuence translational stimulation by miR-122
(Figure 5), but it is possible that additional increases in
the distance between these elements might affect
regulation.
The reporter system used in this study has been very
useful in allowing us to test the roles of speciﬁc features
of the RNA, such as the IRES, in allowing miR-122 to
stimulate translation via the HCV 50-UTR. It has now
been established that miR-122 activates HCV IRES-
driven translation in the context of a replicating virus,
but that this translational regulation is not sufﬁcient to
explain the effect of the miRNA on viral replication
(21). The other mechanism(s) by which miR-122 regulates
HCV replication remains obscure, as new synthesis of
HCV RNA measured by thiouridine labeling was not
affected by miR-122 (39). It is possible that miR-122 inter-
action with HCV RNA changes during the viral life cycle,
which would have consequences for experimental obser-
vations. Subcellular localization of both miR-122 and
HCV RNA may also be important in governing the inter-
action and its effects. Our observations suggest that the
requirements for translation activation are less stringent
than those for full regulation of viral replication.
Mutation of the spacer between the miR-122 seed
matches dramatically reduces HCV replication but does
not inhibit translation activation by miR-122 (24,33)
(Figure 4D), while miR21/122 activates translation of a
reporter RNA with miR-21 seed matches, but does not
allow replication of m21A+B mutant HCV RNA
(Figure 3D and E). This may be because extensive muta-
genesis of the miR-122 binding region has other detrimen-
tal effects on the HCV life cycle, such as inhibiting
recruitment of the viral RNA-dependent RNA polymerase
(RdRP) to negative strand RNA. It is also possible that
the requirements for the miR-122-HCV interaction are
different in a replicating virus to those in a reporter
RNA. Although the reporter system has limitations in
determining the interactions that actually occur during
viral replication, it has allowed us to establish in detail
the minimum RNA requirements for miR-122 to interact
functionally with the HCV 50-UTR, in isolation from
other roles for the HCV 50-UTR in viral replication.
This research represents an important step forward in
our understanding of the mechanistic details of an essen-
tial host–virus interaction and reveals the importance of
specialized features in determining miRNA activity.
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